ArticlemSystems
Genomic Characterization and Copy Number Variation of
Article in mSystems. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 44 citations in OpenAlex.
- Hurdles to horizontal gene transfer: species-specific effects of synonymous variation and plasmid copy number determine antibiotic resistance phenotype.Microbiology (Reading, England) · 2026Article
- Machine Learning-Based Characterization ofPathogens (Basel, Switzerland) · 2025Article
- Decoding the anomalies: a genome-based analysis ofFrontiers in microbiology · 2025Article
- Investigating Anthrax-Associated Virulence Genes among Archival and ContemporaryPathogens (Basel, Switzerland) · 2024Article
- Evaluating the Safety ofMicroorganisms · 2024Article
- Genetic basis of clarithromycin resistance inMicrobiology spectrum · 2024Article
- The variations of native plasmids greatly affect the cell surface hydrophobicity of sphingomonads.mSystems · 2023Article
- Maximizing Heterologous Expression of Engineered Type I Polyketide Synthases: Investigating Codon Optimization Strategies.ACS synthetic biology · 2023Article
- New Research on thePathogens (Basel, Switzerland) · 2023Article
- Retrospective Screening of Anthrax-like Disease Induced byPathogens (Basel, Switzerland) · 2023Article
- High-throughput genetic engineering of nonmodel and undomesticated bacteria via iterative site-specific genome integration.Science advances · 2023Article
- Identification of Universally Applicable and Species-Specific Marker Peptides forLife (Basel, Switzerland) · 2022Article
- Genomic characterization of Bacillus cereus sensu stricto 3A ES isolated from eye shadow cosmetic products.BMC microbiology · 2022Article
- Rapid Identification of Bacillus anthracisMicrobiology spectrum · 2022Article
- Identification of the molecular characteristics ofVeterinary world · 2022Article
- Welder's Anthrax: A Review of an Occupational Disease.Pathogens (Basel, Switzerland) · 2022Review
- Translational demand is not a major source of plasmid-associated fitness costs.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2022Article
- Metabolic profiling reveals nutrient preferences during carbon utilization in Bacillus species.Scientific reports · 2021Article
- Ultrasensitive Detection ofInternational journal of molecular sciences · 2021Article
- Development of a PCR Lateral Flow Assay for Rapid Detection of Bacillus anthracis, the Causative Agent of Anthrax.Molecular biotechnology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bacillus anthracis plasmids pXO1 and pXO2 carry the main virulence factors responsible for anthrax. However, the extent of copy number variation within the species and how the plasmids are related to pXO1/pXO2-like plasmids in other species of the Bacillus cereus
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.